Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotigotine for depressive symptoms in Parkinson's disease
NCT01523301Phase 4Completed
- Sponsor
- UCB
- Start
- Apr 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rotigotine in Parkinson's disease (PD), sponsored by UCB. Started Apr 2012; status: completed.
02
Drugs
rotigotine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01523301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01523301.